|
|
Media partners 
We work with leading magazines and publishers in this arena. If you are interested in becoming a media partner for this event please contact:
Julie Phillips, Marketing Manager
Email: julie.phillips@terrapinn.com
Tel: 02075394336
Fax: 02072421508
|
Genetic Engineering and Biotechnology News (GEN) is the longest-running, most widely read, and largest circulated global biotechnology news publication. Published 21 times a year and recently redesigned to focus on Biobusiness, OMICS, Drug Discovery, Bioprocessing, and Translational Medicine, GEN reports on key news developments and technology trends in the bioindustry.
The vaccine field has been transformed by the technological advances of the past decade. Expert Review of Vaccines provides structured, informed commentary on the development and application of new vaccines and vaccine technologies. This journal aims to provide the key information needed by decision makers in the development and application of vaccines – from concept to the clinic.
“Expert Review of Vaccines provides an important and unique perspective on the key issues facing vaccinology in the 21st century.”
Andrew J Pollard, University of Oxford, UK
For more information go to www.future-drugs.com or email info@future-drugs.com
Drug Delivery Insight: a complete review of the latest commercial and product developments.
Drug Delivery Insight (DDI) takes the hard work out of staying in touch with the companies, products, alliances and research activities shaping the industry. For more information on DDI and to download your free copy visit http://www.espicom.com/ddi
The rapidly expanding fields of molecular diagnostics and applied pharmacogenomics are set to affect every professional involved in the value chain of healthcare delivery – from drug discovery through to patient outcomes in society. Expert Review of Molecular Diagnostics is dedicated to providing a centralised resource for commentary and debate in this field, to help shape decision making among professionals involved in patient care and in the development and delivery of medicines.
For more information please contact info@future-drugs.com or visit our website www.future-drugs.com
We are entering a fascinating era in the study of infectious diseases, in which the magnitude of the challenges we now face is matched only by the enormous growth in our understanding of such diseases. Expert Review of Anti-infective therapy is dedicated to providing critical analysis and commentary on the latest approaches to the management of bacterial, viral, fungal and parasitic infectious disease as those involved in the research and development of anti-infective therapies address these challenges.
For more information please contact info@future-drugs.com or visit our website www.future-drugs.com
Piribo is the source for information products for the global biotechnology, healthcare and pharmaceutical industries.
Use Piribo to browse thousands of business information studies, market reports and books. Find the research you need in your work
Drug Discovery Today is one of the most cited review journals in the field of drug discovery. Since its launch in 1996, it continues to publish reviews of key scientific and strategic issues as well as features, such as opinionated Editorials, interviews with international experts and business trends. Drug Discovery Today covers not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Drug Discovery Today is published monthly in print and digital editions and updated daily on-line on ScienceDirect. Our current ISI impact factor is 7.7.
In 2004, the Drug Discovery Today journal series expanded with the launch of four online-only review journals: Drug Discovery Today: Disease Mechanisms, Drug Discovery Today: Disease Models, Drug Discovery Today: Therapeutic Strategies and Drug Discovery Today: Technologies.
In 2006, Drug Discovery Today launched a digital edition of its magazine. This has allowed us to incorporate new media technology, including videos, animations and sound, all designed to enhance the readers experience.
For more information on Drug Discovery Today please visit our website www.drugdiscoverytoday.com.
www.drugdevelopment-technology.com is used by professionals within the drug development industry as means of creating partnerships and as a key point of reference. This comprehensive resource supplies detailed information on drugs under development and in production, breakdowns of leading drug development companies and suppliers, alongside the latest developments, products and services.
Professionals from around the world use www.drugedevelopment-technology.com to keep abreast of the latest developments and use our resources to make informed decisions. Resources such as free white papers and press releases from the leading drug development companies, comprehensive events listings and much, much more.
Bentham Science Publishers, a major STM journal publisher of 79 titles in 2007, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.4) and Current Pharmaceutical Design (Impact Factor 4.8) :
*FREE online journals and information: www.bentham.org
*Subscribe, Consortia, discounted global licenses and trials: subscriptions@bentham.org
In-PharmaTechnologist.com provides professionals in the industry every day with the latest breaking news on technology and its implications for pharmaceutical manufacturing. This leading online publication allows its readers to focus clearly on the news that affects them and helps drive their business decisions. Join our subscriber base and receive your FREE newsletter now!
BioPharmareporter.com is the leading B2B strategic news resource for the biopharmaceutical market, providing key decision makers and industry professionals with the crucial market intelligence and latest breaking news across Europe, America and Asia Pacific. Subscribe now for the FREE e-newsletter of this complete information source within the pharmaceutical industry.
|
|
|
|
